147 related articles for article (PubMed ID: 17504996)
1. Cyclooxygenase 2 expression in rectal cancer is of prognostic significance in patients receiving preoperative radiotherapy.
de Heer P; Gosens MJ; de Bruin EC; Dekker-Ensink NG; Putter H; Marijnen CA; van den Brule AJ; van Krieken JH; Rutten HJ; Kuppen PJ; van de Velde CJ;
Clin Cancer Res; 2007 May; 13(10):2955-60. PubMed ID: 17504996
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of apoptosis in rectal cancer patients of the dutch total mesorectal excision trial: radiotherapy is redundant in intrinsically high-apoptotic tumors.
de Bruin EC; van de Velde CJ; van de Pas S; Nagtegaal ID; van Krieken JH; Gosens MJ; Peltenburg LT; Medema JP; Marijnen CA
Clin Cancer Res; 2006 Nov; 12(21):6432-6. PubMed ID: 17085656
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
Haffty BG; Yang Q; Moran MS; Tan AR; Reiss M
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1006-13. PubMed ID: 18262731
[TBL] [Abstract][Full Text] [Related]
4. Association between pathologic response in metastatic lymph nodes after preoperative chemoradiotherapy and risk of distant metastases in rectal cancer: An analysis of outcomes in a randomized trial.
Bujko K; Michalski W; Kepka L; Nowacki MP; Nasierowska-Guttmejer A; Tokar P; Dymecki D; Pawlak M; Lesniak T; Richter P; Wojnar A; Chmielik E;
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):369-77. PubMed ID: 17118570
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
[TBL] [Abstract][Full Text] [Related]
6. Caspase-3 activity predicts local recurrence in rectal cancer.
de Heer P; de Bruin EC; Klein-Kranenbarg E; Aalbers RI; Marijnen CA; Putter H; de Bont HJ; Nagelkerke JF; van Krieken JH; Verspaget HW; van de Velde CJ; Kuppen PJ;
Clin Cancer Res; 2007 Oct; 13(19):5810-5. PubMed ID: 17908973
[TBL] [Abstract][Full Text] [Related]
7. Significance of Cox-2 expression in rectal cancers with or without preoperative radiotherapy.
Pachkoria K; Zhang H; Adell G; Jarlsfelt I; Sun XF
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):739-44. PubMed ID: 16199309
[TBL] [Abstract][Full Text] [Related]
8. Preoperative radiotherapy for locally advanced rectal cancer and prognostic factors influencing outcome.
Prausová J; Lohynská R; Kubácková K; Linke Z; Malinová B; Kubala E; Novotný J
Neoplasma; 2006; 53(3):263-8. PubMed ID: 16652199
[TBL] [Abstract][Full Text] [Related]
9. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma.
Peeters KC; Marijnen CA; Nagtegaal ID; Kranenbarg EK; Putter H; Wiggers T; Rutten H; Pahlman L; Glimelius B; Leer JW; van de Velde CJ;
Ann Surg; 2007 Nov; 246(5):693-701. PubMed ID: 17968156
[TBL] [Abstract][Full Text] [Related]
10. Expression of FXYD-3 is an independent prognostic factor in rectal cancer patients with preoperative radiotherapy.
Loftås P; Onnesjö S; Widegren E; Adell G; Kayed H; Kleeff J; Zentgraf H; Sun XF
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):137-42. PubMed ID: 19289258
[TBL] [Abstract][Full Text] [Related]
11. Low BAX protein expression correlates with disease recurrence in preoperatively irradiated rectal carcinoma.
Nehls O; Okech T; Hsieh CJ; Sarbia M; Borchard F; Gruenagel HH; Gaco V; Porschen R; Gregor M; Klump B
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):85-91. PubMed ID: 15629598
[TBL] [Abstract][Full Text] [Related]
12. Epithelial human leukocyte antigen-DR expression predicts reduced recurrence rates and prolonged survival in rectal cancer patients.
de Bruin EC; van de Velde CJ; van Krieken JH; Marijnen CA; Medema JP
Clin Cancer Res; 2008 Feb; 14(4):1073-9. PubMed ID: 18281539
[TBL] [Abstract][Full Text] [Related]
13. Short versus conventional preoperative radiotherapy of rectal cancer: indications.
Klenova A; Georgiev R; Kurtev P; Kurteva G
J BUON; 2007; 12(2):227-32. PubMed ID: 17600877
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 is an independent prognostic factor in gastric carcinoma patients receiving adjuvant chemotherapy and is not associated with EBV infection.
Park ES; Do IG; Park CK; Kang WK; Noh JH; Sohn TS; Kim S; Kim MJ; Kim KM
Clin Cancer Res; 2009 Jan; 15(1):291-8. PubMed ID: 19118057
[TBL] [Abstract][Full Text] [Related]
15. Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence.
Wiig JN; Larsen SG; Dueland S; Giercksky KE
Colorectal Dis; 2008 Jan; 10(1):48-57. PubMed ID: 18028472
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer.
Min BS; Choi YJ; Pyo HR; Kim H; Seong J; Chung HC; Rha SY; Kim NK
Arch Surg; 2008 Nov; 143(11):1091-7; discussion 1097. PubMed ID: 19015468
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial.
den Dulk M; Marijnen CA; Putter H; Rutten HJ; Beets GL; Wiggers T; Nagtegaal ID; van de Velde CJ
Ann Surg; 2007 Jul; 246(1):83-90. PubMed ID: 17592295
[TBL] [Abstract][Full Text] [Related]
18. Survivin expression is an independent prognostic factor in rectal cancer patients with and without preoperative radiotherapy.
Knutsen A; Adell G; Sun XF
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):149-55. PubMed ID: 15337550
[TBL] [Abstract][Full Text] [Related]
19. Distal bowel surgical margin shorter than 1 cm after preoperative radiation for rectal cancer: is it safe?
Rutkowski A; Bujko K; Nowacki MP; Chmielik E; Nasierowska-Guttmejer A; Wojnar A;
Ann Surg Oncol; 2008 Nov; 15(11):3124-31. PubMed ID: 18766404
[TBL] [Abstract][Full Text] [Related]
20. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.
Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S
Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
